Panel · Template
Stakeholder Rehearsal.
LiveStakeholder RehearsalRehearse a hard conversation before it happens: simulated constituencies voice their likely positions, you see where they conflict, the objections to expect with a response for each, what each would need to move, and what a rehearsal cannot tell you.
Add it to your library to reuse from New → From template. Edit the saved copy in your library on the service form.
When to use it
You are about to meet a payer, a regulator, a clinician board, investigators or a committee, and you want to hear the objections and test your answers first.
Who it is for. Leads preparing a high-stakes meeting: access, medical, regulatory, clinical operations, brand and business development leads.
Why a rehearsal must say it is a simulation
Research on persona-conditioned language models finds that persona prompting does not reliably improve alignment with real survey answers, and often worsens it, most for under-represented groups. AI discussion also drifts toward agreement, so every constituency can end up sounding reasonable. This template states at the top that the constituencies are simulated, briefs each seat on what its constituency has said publicly, lets a seat stay unpersuaded, and ends with a required section on what a rehearsal cannot tell you.3,4
What you get
Who was simulated, and a stakeholder map. The question put, the constituencies at the table, and where each sits on power and interest, labeled analyst judgment.1,2
Each constituency’s position. The stance, the claim it rests on with a citation or a gap, and the likely first reaction, from sources the constituency has made public.
Where they conflict. A table of the points on which constituencies pull against each other, with blanks where a constituency would stay silent.
Objections and responses. The objections to expect, each with a response grounded in evidence and the evidence that would support it. This is the rehearsal of the conversation itself.5,6
What each would need to move, and what a rehearsal cannot tell you. At Full depth, what each constituency would need to change its position and the order in which to engage. Every report closes with the limits of the simulation.3
What is in it, by length
| Section | Brief | Standard | Comprehensive |
|---|---|---|---|
| The question put, and who was simulatedThe question and the constituencies | – | ● | ● |
| The stakeholder mapPower and interest of each constituency | – | ● | ● |
| Each constituency's positionThe stance and what it rests on | – | ● | ● |
| Where they conflictThe points of conflict between constituencies | – | ● | ● |
| Objections and responsesThe objections to expect and the answers to prepare | – | ● | ● |
| What each would need to move, and the order to engageWhat would change each position and the sequence | – | – | ● |
| What a rehearsal cannot tell youThe limits of a simulated conversation | – | ● | ● |
A Standard rehearsal has four seats and about four pages. A Full rehearsal has five seats and adds what each would need to move and the order to engage. Light is not offered.
Choosing a length
Choose Standard for most meetings. Choose Full when the order of engagement matters, for example a sequence of meetings with payers, regulators and clinicians.
The standards and practice behind it
The structure and the checks come from published work on stakeholder analysis, advisory committee preparation, risk communication and the limits of simulated respondents. These are the references we drew on and what we took from each. None of their authors has reviewed the template.
| What we took | From | Where it shows |
|---|---|---|
| Place stakeholders by power and interest: manage closely, keep satisfied, keep informed, monitor | Mendelow’s power-interest matrix (1991), as described in teaching summaries1 | The stakeholder map, labeled analyst judgment |
| Rank stakeholders by power, legitimacy and urgency | Toward a Theory of Stakeholder Identification and Salience (Mitchell, Agle and Wood, 1997)2 | The order in which to engage |
| Treat persona-conditioned language models as unreliable stand-ins for real respondents | Assessing the Reliability of Persona-Conditioned LLMs as Synthetic Survey Respondents (arXiv, 2026)3 | The statement at the top and the closing section on what a rehearsal cannot tell you |
| Keep each seat’s stance independent, because AI debate drifts toward agreement | Peacemaker or Troublemaker: How Sycophancy Shapes Multi-Agent Debate (arXiv, 2025)4 | Seats briefed on public statements and allowed to stay unpersuaded |
| Run a realistic mock of the meeting, with experts standing in for the committee, to expose gaps in data and argument | Practitioner guidance on mock FDA advisory committees (RAPS)5 | The objections and responses table |
| Prepare approved, evidence-backed answers to anticipated payer questions | Practitioner guidance on payer objection handling (Clarivate)6 | Each response tied to the evidence that supports it |
What it will not do
It is not research with real stakeholders. The constituencies are simulated by AI specialists from stated sources, and they are not the real people.
It does not predict what the live room will say. It prepares you for the objections you can anticipate.
It does not script a response to be repeated. The responses are for you to test and to adapt.
References
- [1] Mendelow, A. L. Stakeholder mapping. Proceedings of the Second International Conference on Information Systems, Cambridge, MA, 1991. Described in LearnSignal, Mendelow’s matrix. Teaching summary; the original proceedings were not read.
- [2] Mitchell, R. K., Agle, B. R. and Wood, D. J. Toward a theory of stakeholder identification and salience: defining the principle of who and what really counts. Academy of Management Review, 1997;22(4):853–886. The three attributes were confirmed on secondary pages; the paper was not read.
- [3] Taday Morocho et al. Assessing the Reliability of Persona-Conditioned LLMs as Synthetic Survey Respondents. arXiv:2602.18462, 6 February 2026. Abstract read on 8 October 2026: no clear aggregate improvement from persona prompting, worst for under-represented groups, over more than 70,000 survey respondent instances.
- [4] Yao et al. Peacemaker or Troublemaker: How Sycophancy Shapes Multi-Agent Debate. arXiv:2509.23055, 27 September 2025. Abstract read on 8 October 2026.
- [5] Regulatory Affairs Professionals Society. 13 keys to a successful FDA advisory committee meeting. Known from search results; the page was not read in full. The count of 50 anticipated questions in practitioner sources is not used.
- [6] Clarivate. Navigating reimbursement and formulary listing discussions: six tips for more effective objection handling in pharmaceutical market access. Vendor blog, read as search excerpts only.
Links checked 9 October 2026
These are the sources the template drew on. None of their authors or issuers has reviewed it.
About the Panel service
Each panelist answers in their own voice, then the discussion is drawn together. You get the question and who was in the room, every position in full, what they agreed on, where they split, and what follows. Disagreements are written down rather than smoothed into a consensus nobody actually holds, because the split is usually the part you needed.
Use cases for the Stakeholder Rehearsal
9 ready-to-run use cases. Each opens its own page with the question, the specialists, the standards and the references.
To edit a saved template, open New → Panel → From template, or the library rail on the service form.